Fitc-VDVAD-FMK combines a pentapeptide motif with an FMK group and FITC label. The sequence targets proteases preferring alternating polar and hydrophobic residues. Researchers employ it to monitor enzyme activity and identify binding determinants. Its fluorescence facilitates real-time kinetic analysis.
CAT No: HB00049
Fitc-VDVAD-FMK is a synthetic peptide inhibitor distinguished by its conjugation to fluorescein isothiocyanate (FITC), enabling both functional inhibition and fluorescent detection capabilities. As a modified pentapeptide bearing the VDVAD sequence and a fluoromethyl ketone (FMK) reactive group, it is specifically engineered for selective and irreversible inhibition of caspase-2, a cysteine protease centrally involved in the regulation of apoptosis and cell signaling pathways. The FITC label facilitates direct visualization and tracking within cellular systems, making this compound a valuable dual-purpose tool for researchers investigating programmed cell death and protease activity at both biochemical and cellular levels.
Apoptosis research: The primary application of Fitc-VDVAD-FMK is in the study of apoptosis, particularly in dissecting the role of caspase-2 during programmed cell death. By covalently binding to the active site cysteine of caspase-2, the FMK moiety irreversibly inhibits enzymatic activity, allowing researchers to block caspase-2 function in cell-based or in vitro assays. This targeted inhibition helps elucidate the contribution of caspase-2 to apoptotic signaling cascades, facilitating studies on mitochondrial membrane permeabilization, DNA fragmentation, and other downstream events associated with cell demise.
Caspase activity detection: The FITC tag incorporated into the peptide structure enables real-time visualization of inhibitor uptake and binding in live cells or tissue samples. Using fluorescence microscopy or flow cytometry, scientists can monitor the spatial and temporal dynamics of caspase-2 inhibition, assess the efficiency of cell penetration, and quantify the proportion of cells engaged in caspase-mediated processes. This dual functionality streamlines experimental workflows by combining biochemical inhibition with immediate fluorescent readout.
Protease specificity profiling: Fitc-VDVAD-FMK is instrumental in characterizing the selectivity of caspase inhibitors and dissecting the substrate preferences of related proteases. By serving as a competitive tool in enzymatic assays, it helps differentiate between caspase-2-dependent and independent proteolytic events. Such specificity profiling is essential when validating new inhibitors, optimizing assay conditions, or studying cross-reactivity among caspase family members in complex biological samples.
Cell signaling pathway analysis: The ability to selectively inhibit caspase-2 provides researchers with a powerful approach to investigate broader signaling networks that intersect with apoptotic pathways. By modulating caspase-2 activity, it becomes possible to delineate upstream and downstream effectors, map signaling crosstalk, and clarify the molecular context in which caspase-2 exerts its regulatory functions. This approach is particularly valuable in studies exploring stress responses, cell cycle regulation, and developmental biology.
Assay development and optimization: The dual inhibitory and fluorescent properties of this peptide make it a useful reference standard for developing and validating new apoptosis detection assays. Its well-characterized mechanism of action and reliable fluorescence emission allow for robust assay calibration, sensitivity testing, and reproducibility assessments. Incorporating Fitc-VDVAD-FMK into assay platforms enhances the reliability of high-throughput screening, kinetic studies, and mechanistic investigations centered on caspase activity and cell death pathways.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More